Highlights:
- The “major shift” likely to occur following presentation of three large-scale trials evaluating middle meningeal artery (MMA) embolisation for chronic subdural haematoma (SDH)
- Numerous other studies presented for the first time at this year’s International Stroke Conference (ISC; 7–9 February, Phoenix, USA), including ZODIAC, MOST, TWIN2WIN, and more
- US neurointerventionists argue that latest data “affirm” benefits of direct triage in acute stroke care
- PROFILE: Michihiro Tanaka (Chiba, Japan)
- NEUROMODULATION: Former Stimwave chief executive officer (CEO) charged with fraud over “fake, non-functional” device component
